Evaluation of Potential Factors Contributing to Microbiological Treatment Failure in Streptococcus Pyogenes Pharyngitis

Overview

Journal Can J Infect Dis

Date 2007 Dec 27

PMID 18159315

Citations 6

Authors

S M Kuhn

J Preiksaitis

G J Tyrrel

T Jadavji

D Church

H D Davies

Affiliations

Soon will be listed here.

Abstract

Background: A cohort study of children with pharyngitis aged two to 16 years was conducted to assess the role of microbial and host factors in group A beta-hemolytic streptococcus (GABHS) microbiological treatment failure.

Methods: GABHS-infected children had pharyngeal swabs repeated two to five days after completing a 10-day course of penicillin V. M and T typing, and pulsed field gel electrophoresis were performed on the isolates, and the isolates were evaluated for tolerance. Patient characteristics and clinical features were noted and nasopharyngeal swabs for respiratory viruses were taken at enrolment.

Results And Conclusions: Of 286 patients enrolled, 248 (87%) could be evaluated. GABHS was cultured from 104 patients (41.9%), of whom 33 (33.7%) had microbiological treatment failures on follow-up. Although there was a trend toward failure for younger children (mean 6.5+/-2.4 years versus 7.3+/-2.4 years, P=0.07) and M type 12 (24% versus 10%, P=0.08), no factors were associated with treatment failure.

Citing Articles

Impact of Phosphorylcholine Expression on the Adherence and Invasion of to Epithelial Cells.

Iuchi H, Ohori J, Matsuzaki H, Tokushige T, Toge S, Yamashita M Microorganisms. 2022; 10(3).

PMID: 35336104 PMC: 8949955. DOI: 10.3390/microorganisms10030527.

Assessing the Role of Pharyngeal Cell Surface Glycans in Group A Biofilm Formation.

Vyas H, Indraratna A, Everest-Dass A, Packer N, De Oliveira D, Ranson M Antibiotics (Basel). 2020; 9(11).

PMID: 33158121 PMC: 7694240. DOI: 10.3390/antibiotics9110775.

Inhibition of Growth and Gene Expression by PNA-peptide Conjugates in Streptococcus pyogenes.

Patenge N, Pappesch R, Krawack F, Walda C, Mraheil M, Jacob A Mol Ther Nucleic Acids. 2013; 2:e132.

PMID: 24193033 PMC: 3889189. DOI: 10.1038/mtna.2013.62.

In Vitro Antibacterial Activity of Essential Oils against Streptococcus pyogenes.

Sfeir J, Lefrancois C, Baudoux D, Derbre S, Licznar P Evid Based Complement Alternat Med. 2013; 2013:269161.

PMID: 23662123 PMC: 3638616. DOI: 10.1155/2013/269161.

Inhibition of Streptococcus pyogenes biofilm formation by coral-associated actinomycetes.

Nithyanand P, Thenmozhi R, Rathna J, Pandian S Curr Microbiol. 2009; 60(6):454-60.

PMID: 20020301 DOI: 10.1007/s00284-009-9564-y.

References

CATANZARO F, Stetson C, Morris A, CHAMOVITZ R, RAMMELKAMP Jr C, STOLZER B . The role of the streptococcus in the pathogenesis of rheumatic fever. Am J Med. 1954; 17(6):749-56. DOI: 10.1016/0002-9343(54)90219-3. View

Johnson D, Stevens D, Kaplan E . Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis. 1992; 166(2):374-82. DOI: 10.1093/infdis/166.2.374. View

Crowe C, Sanders Jr W, Longley S . Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J Infect Dis. 1973; 128(4):527-32. DOI: 10.1093/infdis/128.4.527. View

Davison V, Sanford B . Adherence of staphylococcus aureus to influenza A virus-infected Madin-Darby canine kidney cell cultures. Infect Immun. 1981; 32(1):118-26. PMC: 350596. DOI: 10.1128/iai.32.1.118-126.1981. View

Sung B, Chonmaitree T, Broemeling L, Owen M, Patel J, Hedgpeth D . Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media. Clin Infect Dis. 1993; 17(1):38-42. DOI: 10.1093/clinids/17.1.38. View

Davies H, McGeer A, Schwartz B, Green K, Cann D, Simor A . Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996; 335(8):547-54. DOI: 10.1056/NEJM199608223350803. View

MAXTED W, Widdowson J, Fraser C, Ball L, Bassett D . The use of the serum opacity reaction in the typing of group-A streptococci. J Med Microbiol. 1973; 6(1):83-90. DOI: 10.1099/00222615-6-1-83. View

Brook I, Gober A . Persistence of group A beta-hemolytic streptococci in toothbrushes and removable orthodontic appliances following treatment of pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1998; 124(9):993-5. DOI: 10.1001/archotol.124.9.993. View

Bingen E, Denamur E, Lambert-Zechovsky N, Braimi N, el Lakany M, Elion J . DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of Streptococcus pyogenes pharyngitis. J Med Microbiol. 1992; 37(3):162-4. DOI: 10.1099/00222615-37-3-162. View

10.

Chonmaitree T, Owen M, Patel J, Hedgpeth D, Horlick D, HOWIE V . Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr. 1992; 120(6):856-62. DOI: 10.1016/s0022-3476(05)81950-x. View

11.

Chonmaitree T, Owen M, HOWIE V . Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis. 1990; 162(2):546-9. DOI: 10.1093/infdis/162.2.546. View

12.

Brook I . Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatr Infect Dis. 1985; 4(5):491-5. DOI: 10.1097/00006454-198509000-00010. View

13.

Kim K, Kaplan E . Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr. 1985; 107(5):681-4. DOI: 10.1016/s0022-3476(85)80392-9. View

14.

Roos K, Grahn E, Holm S, Johansson H, Lind L . Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol. 1993; 25(1-3):141-8. DOI: 10.1016/0165-5876(93)90047-7. View

15.

Kuhn S, Davies H, Katzko G, Jadavji T, Church D . Evaluation of the Strep A OIA assay versus culture methods: ability to detect different quantities of group A Streptococcus. Diagn Microbiol Infect Dis. 1999; 34(4):275-80. DOI: 10.1016/s0732-8893(99)00027-9. View

16.

Smith T, Huskins W, Kim K, Kaplan E . Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr. 1987; 110(5):777-82. DOI: 10.1016/s0022-3476(87)80023-9. View

17.

Glezen W, CLYDE Jr W, Senior R, Sheaffer C, Denny F . Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA. 1967; 202(6):455-60. View

18.

Gaworzewska E, Colman G . Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect. 1988; 100(2):257-69. PMC: 2249231. DOI: 10.1017/s095026880006739x. View

19.

Pichichero M, Margolis P . A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991; 10(4):275-81. DOI: 10.1097/00006454-199104000-00002. View

20.

CATANZARO F, RAMMELKAMP Jr C, CHAMOVITZ R . Prevention of rheumatic fever by treatment of streptococcal infections. II. Factors responsible for failures. N Engl J Med. 1958; 259(2):51-7. DOI: 10.1056/NEJM195807102590201. View